Mechanisms of cancer inhibition by anti-oxidant nutrients

Oral Oncology

Volumn 34, Issue 1, 1998, Pages 24-29

  Shklar, G ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Angiogenesis; Apoptosis; Cancer; Carotenoids; Glutathione; Immune; Micronutrients; Oncogenes; Retinoids; Tocop herols

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BETA CAROTENE; CAROTENOID; CYTOKINE; GLUTATHIONE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN P53; RETINOID; TOCOPHEROL; TRANSFORMING GROWTH FACTOR ALPHA;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER INHIBITION; CANCER REGRESSION; CELL DIFFERENTIATION; CLINICAL TRIAL; DRUG MECHANISM; DRUG POTENTIATION; DRUG SELECTIVITY; HUMAN; LEUKOPLAKIA; MOUTH CANCER; NONHUMAN; NUTRIENT; ONCOGENE H RAS; PRECANCER; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ANTIOXIDANTS; HUMANS; IMMUNITY, CELLULAR; MICRONUTRIENTS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0031945243     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(97)00060-2     Document Type: Review

References (66)

1. [1] Hong WK, Endicott J, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. New England Journal of Medicine 1986;315:1501-1510.
2. [2] Garewal HS, Meyskens FL, Killen D, et al. Response of oral leukoplakia to beta carotene. Journal of Clinical Oncology 1990;8:1711-1720.
3. [3] Lippman SM, Batsakis JG, Toth BB, et al. Comparison of low-dose isotretoin with beta carotene to prevent oral carcinogenesis. New England Journal of Medicine 1993;328:15-20.
4. [4] Benner SC, Winn RJ, Lippman SM, et al. Regression of oral leucoplakia with alpha tocopherol: a community clinical oncology program. Chemopreventative study. Journal of the National Cancer Institute 1993;85:44-48.
5. [5] Garewal HS. Beta carotene and vitamin E in oral cancer prevention. Journal of Cellular Biochemistry 1993;17F:262-269.
6. [6] Blot WJ, Li J, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease specific mortality in the general population. Journal of the National Cancer Institute 1993;85:1483-1491.
7. [7] Chu EW, Malgram RA. An inhibitory effect of vitamin A in the induction of tumours of forestomach and cervix in the Syrian hamster by carcinogenic polcyclic hydrocarbons. Cancer Research 1965;25:884-895.
8. [8] Harman D. Dimethylbenzanthracene-induced cancer. Inhibiting effect of dietary vitamin E. Clinical Research 1969;17:125-129.
9. [9] Bollag W. Prophylaxis of chemically induced benign and malignant tumours by vitamin A acid (retinoic acid). European Journal of Cancer 1972;8:689-693.
10. [10] Sporn MB, Dunlop MN, Newton DL, Smith JM. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Federation Proceedings 1976;35:1332-1338.
11. [11] Schwartz JL, Shklar G. The selective cytotoxic effect of carotenoids and alpha tocopherol on human cancer cell lines in vitro. Journal of Oral and Maxillofacial Surgery 1992;50:367-373.
12. [12] Schwartz JL, Tanaka J, Khandekar V, Herman TS, Teicher B. Beta carotene and/or vitamin E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells. Cancer Chemotherapy and Pharmacology 1991;29:207-213.
13. [13] Menkes MS, Comstock GW, Vuilleumier JP, et al. Serum beta carotene, vitamins A and E, selenium and the risk of lung cancer. New England Journal of Medicine 1986;315:1250-1254.
14. [14] Palan PR, Mikhail MS, Basu J, Romney SL. Plasma levels of antioxidant β-carotene and α-tocopherol in uterine cervix dysplasia and cancer. Nutrition and Cancer 1991;15:13-20.
15. [15] Shklar G. Inhibition of oral mucosal carcinogenesis by vitamin E. Journal of the National Cancer Institute 1982;68:791-797.
16. [16] Trickler D, Shklar G. Prevention by vitamin E of oral carcinogenesis. Journal of the National Cancer Institute 1987;78:165-169.
17. [17] Suda D, Schwartz JL, Shklar G. Inhibition of experimental oral carcinogenesis by topical beta carotene. Carcinogenesis 1986;7:711-715.
18. [18] Schwartz JL, Sloane D, Shklar G. Prevention and inhibition of oral cancer in the hamster buccal pouch model associated with carotenoid immune enhancement. Tumor Biology 1989;10:297-309.
19. [19] Schwartz JL, Shklar G. Regression of experimental oral carcinomas by local injections of beta carotene and canthaxanthin. Nutrition and Cancer 1988;11:35-40.
20. [20] Shklar G, Schwartz JL, Trickler D, Niukian K. Regression by vitamin E of experimental oral cancer. Journal of the National Cancer Institute 1987;8:987-992.
21. [21] Shklar G. Experimental oral pathology in the Syrian hamster. Progress in Experimental Tumor Research 1972;16:518-538.
22. [22] Conti BG, Slaga TJ. The hamster cheek pouch carcinogenesis model. Journal of Cellular Biochemistry 1993;17E:83-90.
23. [23] Ehrlich P. In: Himmelweit F, editor. Collected Papers, Vol. 2. New York: Pergamon Press, 1957. p. 550.
24. [24] Shklar G, Schwartz JL. A common pathway for the destruction of cancer cells: experimental evidence and clinical implications. International Journal of Oncology 1994;4:215-224.
25. [25] Burnet F. The concept of immunologic surveillance. Progress in Experimental Tumor Research 1970;13:1-20.
26. [26] Shklar G, Schwartz J. Tumor necrosis factor in experimental cancer: regression with alpha tocopherol, beta carotene, and algae extract. European Journal of Cancer Clinical Oncology 1988;24:839-850.
27. [27] Flynn EA, Schwartz JL, Shklar G. Sequential mast cell infiltration and degranulation during experimental carcinogenesis. Journal of Cancer Research and Clinical Oncology 1991;117:1-8.
28. [28] Schwartz J, Odukoya O, Stoufi E, Shklar G. Alpha tocopherol alters the distribution of Langerhans cells in DMBA treated hamster cheek pouch epithelium. Journal of Dental Research 1985;64:117-121.
29. [29] Schwartz J, Frim SR, Shklar G. RA can alter the distribution of ATPase-positive Langerhans cells in the hamster cheek pouch in association with DMBA application. Nutrition and Cancer 1985;7:77-84.
30. [30] Stingl G, Katz SL, Green I, Shevach EM. The functional role of Langerhans cells. Journal of Investigative Dermatology 1980;741:315-318.
31. [31] Schwartz JL, Shklar G, Flynn E, Trickler D. The administration of beta carotene to prevent and regress oral carcinoma in the hamster cheek pouch and the associated enhancement of the immune response. Advances in Experimental Medicine and Biology 1990;262:77-93.
32. [32] Schwartz JL, Flynn EA, Shklar G. The effect of carotenoids on the antitumour immune response in vivo and in vitro with hamster and mouse immune effectors. Annals of the New York Academy of Sciences 1990;587:92-109.
33. [33] Shklar G, Schwartz JL, Trickler DP, Reid S. Prevention of experimental oral cancer and immunostimulation by vitamin E (immunosurveillance). Journal of Oral Pathology and Medicine 1990;19:60-64.
34. [34] Schwartz JL, Shklar G, Trickler D. p53 in the anticancer mechanism of vitamin E. Oral Oncology, European Journal of Cancer 1993;29B:313-318.
35. [35] Lane DP. p53 guardian of the genome. Nature 1992;358:15-16.
36. [36] Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research 1994;54:4855-4878.
37. [37] Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
38. [38] Somers KD, Merrick MA, Lopez ME, et al. Frequent p53 mutations in head and neck cancer. Cancer Research 1992;52:5997-6000.
39. [39] Schwarz JL, Antoniades DZ, Zhao S. Molecular aid biochemical reprogramming of oncogenesis through the activity of antioxidants and prooxidants. Annals of the New York Academy of Sciences 1992;686:262-279.
40. [40] Schwartz JL, Singh RP, Teicher B, et al. The induction of a 70kD protein associated with the selective cytotoxic activity of beta carotene in human epidermal carcinoma. Biochemical and Biophysical Research Communications 1990;169:941-946.
41. [41] Morimoto RI. Heat shock: the role of transient inducible response in cell damage, transformation, and differentiation. Cancer Cell 1991;3:295-301.
42. [42] Shklar G, Schwartz JL. Vitamin E inhibits experimental carcinogenesis and tumour angiogenesis. Oral Oncology, European Journal of Cancer 1996;32B: 114-119.
43. [43] Schwartz JL, Shklar G. Glutathione inhibits experimental oral carcinogenesis, p53 expression and angiogenesis. Nutrition and Cancer 1996;26:229-236.
44. [44] Folkman J. What is the evidence that tumours are angiogenesis dependent? Journal of the National Cancer Institute 1989;82:4-6.
45. [45] Folkman J, Watson K, Ingber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
46. [46] Wong DTW. TGFα and oral carcinogenesis. Oral Oncology, European Journal of Cancer 1993;29B:3-7.
47. [47] Schwartz JL, Shklar G. Retinoid and carotenoid angiogenesis: a possible explanation for enhanced oral carcinogenesis. Nutrition and Cancer 1997;27:192-199.
48. [48] Fuchs E, Green H. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 1981;25:615-625.
49. [49] Sporn MB, Roberts AB. Role of retinoids in differentiation and carcinogenesis. Cancer Research 1983;43:3034-3040.
50. [50] Jetten AM. Multi-stage program of differentiation in human epidermal keratinocytes: regulation by retinoids. Journal of Investigative Dermatology 1990;95:44-46.
51. [51] Kopan R, Traska G, Fuchs E. Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization. Journal of Cell Biology 1987;105:427-440.
52. [52] Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB Journal 1996;10:1002-1013.
53. [53] Harris H. The role of differentiation in the suppression of malignancy. Journal of Cell Science 1990;97:5-10.
54. [54] Lotan R. Suppression of squamous cell carcinoma growth and differentiation by retinoids. Cancer Research 1994;54(Suppl): 1987-1990.
55. [55] Shklar G, Schwartz JL, Trickler DP, Reid S. Regression of experimental cancer by oral administration of combined alpha tocopherol and beta carotene. Nutrition and Cancer 1989;12:321-325.
56. [56] Shklar G, Schwartz JL, Trickler DP, Reid-Cheverie S. The effectiveness of a mixture of beta carotene, alpha tocopherol, glutathione and ascorbic acid for cancer chemoprevention. Nutrition and Cancer 1993;20:145-151.
57. [57] Teicher BA, Schwartz JL, Holden SA, Ara G, Northey D. In vivo modulation of several antitumor agents by beta carotene. Cancer Chemotherapy and Pharmacology 1994;34:235-241.
58. [58] Schwartz JL, Flynn EA, Trickler DP, Shklar G. Directed lysis of experimental cancer by beta carotene in liposomes. Nutrition and Cancer 1991;16:107-124.
59. [59] Bendich AB, Machlin LJ. Safety of oral intake of vitamin E. American Journal of Clinical Nutrition 1988;48:612-619.
60. [60] Meydani SN, Meydani M, Rall LC, Morrow F, Blumberg JB. Assessment of the safety of high-dose, short-term supplementation with vitamin E in healthy older adults. American Journal of Clinical Nutrition 1994;60:704-709.
61. [61] Suda D, Schwartz J, Shklar G. GGT reduction in beta carotene inhibition of hamster buccal pouch carcinogenesis. European Journal of Cancer Clinical Oncology 1987;23:43-46.
62. [62] Packer L, Fuchs J. Vitamin E in Health and Disease. New York: Marcel Dekker, 1993.
63. [63] Meydani SN, Meydani M, Blumberg JB, Leka LS, Siber G, et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. Journal of the American Medical Association 1997;277:1380-1386.
64. [64] Kaugers GE, Silverman S, Lovas JGL, Brandt RB, Riley WT, et al. A clinical trial of antioxidant supplements in the treatment of oral leukoplakia. Oral Surgery 1994;78:462-468.
65. [65] Benner SE, Wargovich ML, Lippman SM, Fisher R, Velasco M, et al. Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia. Cancer Epidemiology, Biomarkers, Prevention 1994;3:73-76.
66. [66] Garewal HS, Schantz S. Emerging role of beta-carotene and antioxidant nutrients in prevention of oral cancer. Archives of Otolaryngology Head Neck Surgery 1995;121:141-144.